Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib

Annals of Surgery

Volumn 242, Issue 1, 2005, Pages 140-146

  Greene, Arin K ^a   Alwayn, Ian P J ^a   Nose, Vania ^a   Flynn, Evelyn ^a   Sampson, David ^a   Zurakowski, David ^a   Folkman, Judah ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; NAPROXEN; ROFECOXIB; SILICONE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INFERTILITY; INTESTINE OBSTRUCTION; MALE; MOUSE; NONHUMAN; PERITONEUM ADHESION; PRIORITY JOURNAL;

ADHESIONS; ANIMALS; BIOPSY, NEEDLE; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INTESTINAL OBSTRUCTION; MALE; MICE; MICE, INBRED C57BL; PROBABILITY; PYRAZOLES; RANDOM ALLOCATION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SULFONAMIDES;

EID: 21444453926     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000167847.53159.c1     Document Type: Article

References (47)

1. Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl. 1997;577:5-9.
2. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999;353:1476-1480.
3. Kossi J. Population-based study of the surgical workload and economic impact of bowel obstruction caused by postoperative adhesions. Br J Surg. 2003;90:1441-1444.
4. Menzies D, Ellis H. Intestinal obstruction from adhesions: how big is the problem? Ann R Coll Surg Engl. 1990;72:60-63.
5. Menzies D, Parker M, Hoare R, et al. Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl. 2001;83:40-46.
6. Ray NF, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998;186:1-9.
7. DiZerega GS, Campeau JD. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update. 2001;7:547-555.
8. Saed GM, Munkarah AR, Diamond MP. Cyclooxygenase-2 is expressed in human fibroblasts isolated from intraperitoneal adhesions but not from normal peritoneal tissues. Fertil Steril. 2003;79:1404-1408.
9. Wiczyk HP, Grow DR, Adams LA, et al. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril. 1998;69:511-516.
10. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl. 1997;577:17-23.
11. Rout UK, Oommen K, Diamond MP. Altered expressions of VEGF mRNA splice variants during progression of uterine-peritoneal adhesions in the rat. Am J Reprod Immunol. 2000;43:299-304.
12. Chiang SC, Cheng CH, Moulton KS, et al. TNP-470 inhibits intraabdominal adhesion formation. J Pediatr Surg. 2000;35:189-196.
13. Masferrer JL, Koki A, Seibert K. COX-2 inhibitors. A new class of antiangiogenic agents. Ann NY Acad Sci. 1999;889:84-86.
14. Masferrer JL, Leahy KM, Koki AT, et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 2000;60:1306-1311.
15. Dicker AP, Williams TL, Grant DS. Targeting angiogenic processes by combination rofecoxib and ionizing radiation. Am J Clin Oncol. 2001; 24:438-442.
16. Leahy KM, Ornberg RL, Wang Y, et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 2002;62:625-631.
17. DeVirgilio C. Fibrin glue reduces the severity of intra-abdominal adhesions in a rat model. Am J Surgeons. 1999;178:577-580.
18. Farag MM, Salama MA, Abou-Basha L. Experimental murine schistosomiasis: reduced hepatic morbidity after pre- and/or post-infection treatment with ibuprofen or diclofenac sodium. Ann Trop Med Parasitol. 1995;89:497-504.
19. Cicala C, Ianaro A, Fiorucci S, et al. NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol. 2000;130:1399-1405.
20. Jablonski P, Howden BO. Oral buprenorphine and aspirin analgesia in rats undergoing liver transplantation. Lab Anim. 2002;36:134-143.
21. Yamamoto T, Sakashita Y, Nozaki-Taguchi N. Anti-allodynic effects of oral COX-2 selective inhibitor on postoperative pain in the rat. Can J Anaesth. 2000;47:354-360.
22. Laudanno OM, Cesolari JA, Esnarriaga J, et al. Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci. 2001;46:779-784.
23. Montz FJ, Holschneider CH, Bozuk M, et al. Interleukin 10: ability to minimize postoperative intraperitoneal adhesion formation in a murine model. Fertil Steril. 1994;61:1136-1140.
24. DiZerega G. Use of Insulates to prevent intraperitoneal adhesions; crystalloid and dextran. Infert Reprod Med Clin. 1994;5:463.
25. Rodgers KE, Johns DB, Girgis W, et al. Reduction of adhesion formation with hyaluronic acid after peritoneal surgery in rabbits. Fertil Steril. 1997;67:553-558.
26. Panay N, Lower AM. New directions in the prevention of adhesion in laparoscopic surgery. Curr Opin Obstet Gynecol. 1999;11:379-385.
27. Soules MR, Dennis L, Bosarge A, et al. The prevention of postoperative pelvic adhesions: an animal study comparing barrier methods with dextran 70. Am J Obstet Gynecol. 1982;143:829-834.
28. Wiseman DM, Trout JR, Diamond MP. The rates of adhesion development and the effects of crystalloid solutions on adhesion development in pelvic surgery. Fertil Steril. 1998;70:702-711.
29. LeGrand EK, Rodgers KE, Girgis W, et al. Efficacy of tolmetin sodium for adhesion prevention in rabbit and rat models. J Surg Res. 1994;56: 67-71.
30. LeGrand EK, Rodgers KE, Girgis W, et al. Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion-prevention model. J Invest Surg. 1995;8:187-194.
31. Wiseman DM, Huang WJ, Johns DB, et al. Time-dependent effect of tolmetin sodium in a rabbit uterine adhesion model. J Invest Surg. 1994;7:527-532.
32. Haney AF, Doty E. A barrier composed of chemically cross-linked hyaluronic acid (Incert) reduces postoperative adhesion formation. Fertil Steril. 1998;70:145-151.
33. Wallwiener D, Meyer A, Basiert G. Adhesion formation of the parietal and visceral peritoneum: an explanation for the controversy on the use of autologous and alloplastic barriers? Fertil Steril. 1998;69:132-137.
34. Rodgers K, Cohn D, Hotovely A, et al. Evaluation of polyethylene glycol/polylactic acid films in the prevention of adhesions in the rabbit adhesion formation and reformation sidewall models. Fertil Steril. 1998;69:403-408.
35. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril. 1998;69:1067-1074.
36. Bowers D, Raybon RB, Wheeless CR Jr. Hyaluronic acid- carboxymethylcellulose film and perianastomotic adhesions in previously irradiated rats. Am J Obstet Gynecol. 1999;181:1335-1337; discussion 1137-1138.
37. Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol. 1997;24(suppl):6-8.
38. Fu JY, Masferrer JL, Seibert K, et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265:16737-16740.
39. Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1 beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001;410:471-475.
40. Wilkinson-Berka JL, Alousis NS, Kelly DJ, et al. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2003;44:974-979.
41. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705-716.
42. Ghosh AK, Hirasawa N, Niki H, et al. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats. J Pharmacol Exp Ther. 2000;295:802-809.
43. Kusunoki N, Yamazaki R, Kawai S. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis Rheum. 2002;46:3159-3167.
44. Guvenal T, Cetin A, Ozdemir H, et al. Prevention of postoperative adhesion formation in rat uterine horn model by nimesulide: a selective COX-2 inhibitor. Hum Reprod. 2001;16:1732-1735.
45. Nagler A, Genina O, Lavelin I, et al. Haloguginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model. Am J Obstet Gynecol. 1999; 180:558-563.
46. Elkin M, Miao HQ, Nagler A, et al. Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 2000; 15:2477-2485.
47. Wiseman D. Animal adhesion models: design, variables and relevance. In: diZerega et al, eds. Peritoneal Surgery. New York: Springer-Verlag, 2000:459-478.